- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Theses and Dissertations /
- Exploring novel human pancreatic alpha-amylase inhibitors...
Open Collections
UBC Theses and Dissertations
UBC Theses and Dissertations
Exploring novel human pancreatic alpha-amylase inhibitors : a departure from carbohydrate-based therapeutics Tysoe, Christina Rose
Abstract
Human pancreatic α-amylase (HPA) catalyzes a key step in the degradation of ingested starch. Accordingly HPA activity has been positively correlated to post-prandial blood glucose levels and has been identified as a viable target for inhibition and the development of therapeutics towards the treatment of diabetes and obesity. This work directs the hunt away from traditional saccharide-based inhibitors, which represent all carbohydrate metabolism therapeutics currently in use, to novel inhibitors with improved selectivity and potency. In Chapter 2, the synthesis of flavonol-based HPA inhibitors based upon the structure of Montbretin A, a complex flavonol glycoside, is explored. Through the synthesis of a library of Montbretin A analogues we were able to identify an inhibitor of HPA with a KI of 44 nM that formed new interactions within the amylase active site. Chapter 3 details work on the peptide-based HPA inhibitor helianthamide previously isolated from the Caribbean Sea anemone Stichodactyla helianthus. Recombinant expression of helianthamide as a fusion peptide was achieved in Escherichia coli and Pichia pastoris. Kinetic analysis indicated that recombinant helianthamide is one of the most potent HPA inhibitors known to date, with a KI of 0.01 nM. Structural analysis of the recombinant material indicated that it contained three disulfide bonds in a 1-5, 2-4, 3-6 pattern. Site-directed mutagenesis of helianthamide indicated that disruption of disulfide bonds led to a large decrease in potency, while alanine variants of residues forming polar contacts with HPA’s active site residues led to smaller decreases in potency, indicating that the intact tertiary structure of helianthamide is necessary for blockage of the amylase active site. Small peptides were synthesized based on the sequence of helianthamide, but most showed modest or no inhibition of HPA.
Item Metadata
Title |
Exploring novel human pancreatic alpha-amylase inhibitors : a departure from carbohydrate-based therapeutics
|
Creator | |
Publisher |
University of British Columbia
|
Date Issued |
2018
|
Description |
Human pancreatic α-amylase (HPA) catalyzes a key step in the degradation of ingested starch. Accordingly HPA activity has been positively correlated to post-prandial blood glucose levels and has been identified as a viable target for inhibition and the development of therapeutics towards the treatment of diabetes and obesity. This work directs the hunt away from traditional saccharide-based inhibitors, which represent all carbohydrate metabolism therapeutics currently in use, to novel inhibitors with improved selectivity and potency. In Chapter 2, the synthesis of flavonol-based HPA inhibitors based upon the structure of Montbretin A, a complex flavonol glycoside, is explored. Through the synthesis of a library of Montbretin A analogues we were able to identify an inhibitor of HPA with a KI of 44 nM that formed new interactions within the amylase active site. Chapter 3 details work on the peptide-based HPA inhibitor helianthamide previously isolated from the Caribbean Sea anemone Stichodactyla helianthus. Recombinant expression of helianthamide as a fusion peptide was achieved in Escherichia coli and Pichia pastoris. Kinetic analysis indicated that recombinant helianthamide is one of the most potent HPA inhibitors known to date, with a KI of 0.01 nM. Structural analysis of the recombinant material indicated that it contained three disulfide bonds in a 1-5, 2-4, 3-6 pattern. Site-directed mutagenesis of helianthamide indicated that disruption of disulfide bonds led to a large decrease in potency, while alanine variants of residues forming polar contacts with HPA’s active site residues led to smaller decreases in potency, indicating that the intact tertiary structure of helianthamide is necessary for blockage of the amylase active site. Small peptides were synthesized based on the sequence of helianthamide, but most showed modest or no inhibition of HPA.
|
Genre | |
Type | |
Language |
eng
|
Date Available |
2019-03-31
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
Attribution-NonCommercial-NoDerivatives 4.0 International
|
DOI |
10.14288/1.0364285
|
URI | |
Degree | |
Program | |
Affiliation | |
Degree Grantor |
University of British Columbia
|
Graduation Date |
2018-05
|
Campus | |
Scholarly Level |
Graduate
|
Rights URI | |
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International